ANGPT2, Human (Nesvacumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-ANGPT2, Human (Nesvacumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityANGPT2, Human (Nesvacumab biosimilar)
CloneNesvacumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human ANGPT2 Recombinant Antibody. Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema. This drug is being developed by Regeneron Pharmaceuticals.
Immunogenn/a
Other NamesAnti-ANGPT2 Recombinant Antibody, Research Grade Nesvacumab, Anti-Human ANGPT2 Recombinant Antibody, REGN-910, Antibody Drug Analogues, Monoclonal Antibody, YR1297, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1296818-77-3
Catalog #YR1297
Priceplease inquire
Order / More InfoANGPT2, Human (Nesvacumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.